> Alimera Sciences Announces Italian Patients Now Being Treated With ILUVIENŽ ILUVIEN is fully reimbursable as a hospital-administered therapy in Italy
"The only thing worse than being blind is having sight but no vision."
Helen Keller

 
 
Focus On vision science related meetings & events around the world. To suggest a meeting or event to be published in this section please send an email stating event title, dates, subject...
 
SIFI, the leading Italian ophthalmic company, has been focused on Eye Care since its foundation in 1935... Download Company Brief Journalists and media operators can write to press@sifigroup.com...
 
L'Oculista Italiano is an Ophthalmology journal, founded in 1968, publishing scientific articles, reviews and interviews with the aim to contribute to scientific and professional update of...

On our Social Channels

From our News Center

ATLANTA, July 12, 2017 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (NASDAQ:ALIM) (Alimera), a leader in the commercialization, research, and development of prescription ophthalmic pharmaceuticals,...
 

 

07 June

The paper by Prof. Gerd U. Auffarth is among the best papers at the 2017 ASCRS-ASOA Symposium & Congress, May 5–9, 2017, Los Angeles   The final General Session...
Follow Us!